Synthesis and Solid State Pharmaceutical Centre (SSPC), Bernal Institute , University of Limerick , Limerick V94 T9PX , Ireland.
Mol Pharm. 2018 Nov 5;15(11):5327-5335. doi: 10.1021/acs.molpharmaceut.8b00797. Epub 2018 Oct 11.
The Flory-Huggins (F-H) solubility equation has been widely used to describe the solubility of a small-molecule drug in a polymeric carrier and thus determine the design space available for formulating a stable amorphous solid dispersion. The F-H interaction parameter (χ) describes the thermodynamic properties of drug-polymer solutions and accounts for any enthalpic and entropic changes in solubility. Many studies have found that for a limited compositional range, χ varies proportionally to the inverse of the melting temperature of the drug. We explored this relationship using a highly sensitive DSC technique to detect remaining residual crystalline active pharmaceutical ingredients (APIs) following annealing of ball milled mixtures of crystalline itraconazole (ITZ) and either Soluplus or hydroxypropyl methylcellulose phthalate (HPMCP) at temperatures near the estimated solubility curve. Depending on the experimental approach taken, the measurement of drug-polymer solubility can be restricted to mixtures with a high proportion of drug, but in this study, solubility was experimentally determined for mixtures with API content as low as 10 wt %. Results suggest that the proposed linear relationship does not extend to compositions with smaller amounts of API, instead indicating that χ was both temperature- and composition-dependent for the systems studied. The feasibility of this technique to measure interactions in a ternary system containing itraconazole and both polymers was also determined; ITZ-HPMCP exhibited the most favorable values of χ, while ITZ-Soluplus and ITZ-Soluplus-HPMCP demonstrated similar interaction parameters.
Flory-Huggins(F-H)溶解度方程已被广泛用于描述小分子药物在聚合物载体中的溶解度,从而确定可用于制备稳定无定形固体分散体的设计空间。F-H相互作用参数(χ)描述了药物-聚合物溶液的热力学性质,并解释了溶解度的任何焓变和熵变。许多研究发现,在有限的组成范围内,χ与药物的熔点的倒数成正比。我们使用高度灵敏的 DSC 技术来探测球磨混合物中剩余的结晶活性药物成分(API),该混合物由研磨后的伊曲康唑(ITZ)与 Soluplus 或羟丙基甲基纤维素邻苯二甲酸酯(HPMCP)在接近估计溶解度曲线的温度下退火。根据所采用的实验方法,药物-聚合物溶解度的测量可能仅限于高药物比例的混合物,但在本研究中,API 含量低至 10wt%的混合物的溶解度也通过实验确定。结果表明,所提出的线性关系不适用于 API 含量较少的组合物,而是表明 χ 对于所研究的系统既依赖于温度又依赖于组成。还确定了该技术用于测量包含伊曲康唑和两种聚合物的三元系统中相互作用的可行性;ITZ-HPMCP 表现出最有利的 χ 值,而 ITZ-Soluplus 和 ITZ-Soluplus-HPMCP 则表现出相似的相互作用参数。